Literature DB >> 23769555

Reliability and validity of the Chinese version of the Scale for Assessment and Rating of Ataxia.

Song Tan1, Hui-xia Niu, Lu Zhao, Yuan Gao, Jia-meng Lu, Chang-he Shi, Chandra Avinash, Rui-hao Wang, Yu-ming Xu.   

Abstract

BACKGROUND: The Scale for the Assessment and Rating of Ataxia (SARA) was shown to be a reliable and valid measurement for patients with spinocerebellar ataxia (SCA). The Brazilian version and the Japanese version of SARA were favorable for good reliability and validity. This study aimed to translate SARA into Chinese and test its reliability and validity in measurement of cerebellar ataxia.
METHODS: SARA was translated into Chinese. A total 39 patients with degeneration cerebellar ataxia were evaluated independently by two neurologists with the Chinese version of SARA. Then the patients were evaluated by one of above neurologists with International Cooperative Ataxia Rating Scale (ICARS). The statistical analyses were performed using SPSS 17.0 for Windows.
RESULTS: The Cronbach's alpha coefficient of the Chinese version of SARA was 0.78, which represents a good internal consistence. The correlation coefficient of the Chinese version of SARA scores between the two evaluators was 0.86, illustrating that the inter-rater reliability of Chinese version of SARA was good. The correlation coefficient between the Chinese version of SARA and ICARS was 0.91, illustrating that the criterion validity of Chinese version of SARA was not bad.
CONCLUSIONS: The Chinese version of SARA is reliable and effective for the assessment of degeneration cerebellar ataxia. Compared with ICARS, the evaluation of Chinese version of SARA is more objective, the assessment time is shortened, and the maneuverability is better.

Entities:  

Mesh:

Year:  2013        PMID: 23769555

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  3 in total

1.  Oculomotor deficits in spinocerebellar ataxia type 3: Potential biomarkers of preclinical detection and disease progression.

Authors:  Chao Wu; Ding-Bang Chen; Li Feng; Xiang-Xue Zhou; Ji-Wei Zhang; Hua-Jing You; Xiu-Ling Liang; Zhong Pei; Xun-Hua Li
Journal:  CNS Neurosci Ther       Date:  2017-02-13       Impact factor: 5.243

Review 2.  Current behavioral assessments of movement disorders in children.

Authors:  Tetsuya Asakawa; Kenji Sugiyama; Takao Nozaki; Tetsuro Sameshima; Susumu Kobayashi; Liang Wang; Zhen Hong; Shu-Jiao Chen; Can-Dong Li; Ding Ding; Hiroki Namba
Journal:  CNS Neurosci Ther       Date:  2018-07-24       Impact factor: 5.243

3.  Nerve growth factor for the treatment of spinocerebellar ataxia type 3: an open-label study.

Authors:  Song Tan; Rui-Hao Wang; Hui-Xia Niu; Chang-He Shi; Cheng-Yuan Mao; Rui Zhang; Bo Song; Shi-Lei Sun; Xin-Jing Liu; Hai-Man Hou; Yu-Tao Liu; Yuan Gao; Hui Fang; Xiang-Dong Kong; Yu-Ming Xu
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.